Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 27 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 8735153

    Modulation of stem cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted May 27, 2014 · Expires May 22, 2034

    granted

  2. US 8728806

    Methods and compositions related to Th-1 dendritic cells

    The Board of Regents of the University of Texas System · Granted May 20, 2014 · Expires May 15, 2034

    granted

  3. US 8722667

    Compositions and methods for inhibiting the proliferation of cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 13, 2014 · Expires May 8, 2034

    granted

  4. US 8716017

    Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

    San Diego Regenerative Medicine Institute · Granted May 6, 2014 · Expires May 1, 2034

    granted

  5. US 8697048

    Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

    Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  6. US 8691963

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  7. US 8673292

    Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  8. US 8669101

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  9. US 8663987

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  10. US 8658168

    Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  11. US 8658158

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  12. US 8652458

    Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  13. US 8647837

    Artificial tissue constructs comprising alveolar cells and methods for using the same

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  14. US 8642561

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  15. US 8628962

    Differentiation of stem cells into dopaminergic cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  16. US 8597946

    Enhanced dendritic cells for cancer immunotherapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  17. US 8592384

    Micro-RNA's that regulate muscle cells

    The Board of Regents of the University of Texas System · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  18. US 8591862

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  19. US 8545888

    Tendon stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  20. US 8518390

    Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  21. US 8512712

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  22. US 8491883

    Treatment of amyotrophic lateral sclerosis using umbilical derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  23. US 8491884

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  24. US 8481313

    Retinal pigment epithelial stem cells

    REGENERATIVE RESEARCH FOUNDATION · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.